Welcome to LookChem.com Sign In|Join Free
  • or
Benzeneacetic acid, 3-(trimethylsilyl)-, also known as 3-(trimethylsilyl)benzeneacetic acid, is an organic compound with the chemical formula C11H18O2Si. It is a derivative of benzeneacetic acid, where a trimethylsilyl group (Si(CH3)3) is attached to the 3-position of the benzene ring. This modification introduces unique chemical properties, such as increased lipophilicity and stability, which can be beneficial in various applications, including the synthesis of pharmaceuticals and the development of new materials. The compound is a colorless liquid with a molecular weight of 210.35 g/mol and is insoluble in water but soluble in organic solvents. It is commonly used as a protecting group in organic synthesis and as an intermediate in the preparation of other organosilicon compounds.

5112-64-1

Post Buying Request

5112-64-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5112-64-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 5112-64-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,1,1 and 2 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 5112-64:
(6*5)+(5*1)+(4*1)+(3*2)+(2*6)+(1*4)=61
61 % 10 = 1
So 5112-64-1 is a valid CAS Registry Number.

5112-64-1Relevant academic research and scientific papers

Studies on the synthesis and biological properties of non-carrier-added [125I and 131I]-labeled arylalkylidenebisphosphonates: Potent bone-seekers for diagnosis and therapy of malignant osseous lesions

?rstad, Erik,Hoff, Per,Skatteb?l, Lars,Skretting, Arne,Breist?l, Knut

, p. 3021 - 3032 (2007/10/03)

Arylalkylidenebisphosphonates labeled with nca [125I or 131I] have been synthesized and their biological function investigated. The label was attached to the aromatic group in high yield and under mild conditions by means of iododesi

Bis-phosphonate compounds

-

, (2008/06/13)

The present invention provides a pharmaceutical compound, or pharmaceutically acceptable salt thereof, for use in medicine, wherein said compound is of formula I wherein R is a pharmaceutically active moiety; Ar is an aromatic moiety; X is a linker group; and Y is a moiety comprising two phosphonate groups. Further aspects of the invention relate to a method for palliative and curative treatment of bone disorders and cancer related disorders, such as breast cancer.

Bis-phosphonate compounds

-

, (2008/06/13)

The present invention provides a pharmaceutical compound, or pharmaceutically acceptable salt thereof, for use in medicine, wherein said compound is of formula I wherein R is a pharmaceutically active moiety; Ar is an aromatic moiety; X is a linker group; and Y is a moiety comprising two phosphonate groups. Further aspects of the invention relate to a method for palliative and curative treatment of bone disorders and cancer related disorders, such as breast cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5112-64-1